StrategIQ Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
StrategIQ Financial Group's ELV Position: Q4 2023 in Review
StrategIQ Financial Group increased its Elevance Health (ELV) stake by 42% in Q4 2023, buying an estimated $105K and bringing the position to 770 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #244.
StrategIQ Financial Group first reported a position in ELV in Q1 2022 and has held it in 7 quarters since. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.
- StrategIQ Financial Group held 770 shares of Elevance Health worth $363K as of Q4 2023.
- StrategIQ Financial Group bought 227 Elevance Health shares in Q4 2023, an estimated $105K.
- Elevance Health made up 0.04% of StrategIQ Financial Group's portfolio in Q4 2023, its #244 holding.
- StrategIQ Financial Group first reported a position in Elevance Health in Q1 2022 and has held it in 7 quarters since.
- 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.
Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.